Dignitana AB produces
The DigniCap Scalp Cooling System to minimize hair loss from chemotherapy.
Click HERE to learn more about DigniCap Delta.
For product information, visit dignicap.com
ABOUT DIGNITANA READ MORE
Company Profile
Dignitana is a Swedish medical technology company publicly traded on Nasdaq First North Growth Market. Company headquarters are in Lund, Sweden and operations are based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy.
The company develops, produces and markets The DigniCap® Scalp Cooling System. It is a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy to improve well-being and quality of life. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. In 2017, Dignitana received an expanded clearance from the FDA, allowing DigniCap to be used by patients receiving chemotherapy to treat solid tumors from breast cancer as well as those from prostate, ovarian, uterine, lungs and other tissues.
NEWS
Offentligt uppköpserbjudande 2025
- Paxman fullföljer uppköpserbjudandet till aktieägarna i Dignitana och förlänger acceptperioden (8 Maj 2025) – Svenska
- Paxman lämnar ett rekommenderat uppköpserbjudande till aktieägarna i Dignitana- Svenska
- Uttalande från Dignitanas styrelse med anledning av Paxmans offentliga uppköpserbjudande- Svenska
- Paxman offentliggör erbjudandehandling och informationsdokument med anledning av det rekommenderade uppköpserbjudandet till aktieägarna i Dignitana – Svenska
- Erbjudande till aktieägarna i Dignitana AB – Svenska
- För mer information besök Paxman Corporate Governance sidan och navigera till Regulatory documents.
Public Takeover Offer 2025
- Paxman completes public offer to Dignitana shareholders and extends acceptance period (8 May 2025) – English
- Paxman is making a recommended takeover offer to Dignitana shareholders – English
- Statement by the Board of Directors of Dignitana regarding the public offer from Paxman – English
- Paxman publishes offer document and information document in connection with the recommended takeover bid to the shareholders of Dignitana – English
- Offer to the shareholders of Dignitana AB – Swedish
- For more information visit the Paxman Corporate Governance page and navigate to Regulatory documents.
VIDEOS
Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.
HEADQUARTERS
Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90
UNITED STATES
Dignitana
10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 469-917-5555
HEADQUARTERS
Dignitana S.r.l.
Corso di Porta Nuova, 46
20121 Milan, Italy